We are live on
!
Find out more
PA
Profund Advisors Portfolio holdings
AUM
$2.72B
1-Year Est. Return
47.27%
This Fund
S&P 500
This Quarter
Est. Return
+2.46%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.42B
AUM Growth
–
Cap. Flow
+$1.43B
Cap. Flow
% of AUM
101.06%
Top 10 Holdings %
Top 10 Hldgs %
18.66%
Holding
1,386
New
1,386
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$41.1M |
| 2 |
Amgen
AMGN
|
+$40.3M |
| 3 |
AbbVie
ABBV
|
+$32.9M |
| 4 |
ExxonMobil
XOM
|
+$26.5M |
| 5 |
Biogen
BIIB
|
+$26.2M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.46% |
| 2 | Technology | 11.46% |
| 3 | Financials | 10.21% |
| 4 | Energy | 9.8% |
| 5 | Consumer Discretionary | 7.05% |
Similar funds
MASUI
XL
MSL
CA
APSPRSPT
TAM
NCM
GC
Profund Advisors's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Profund Advisors, which disclosed 1,386 positions worth $1.42B. Its ten largest holdings account for 19% of the portfolio.
Its largest position is Gilead Sciences: 789,103 shares worth $40.4M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, followed by Technology and Financials.
- Profund Advisors's largest Q2 2013 buy was Gilead Sciences: 789,103 shares worth $40.4M.
- Profund Advisors's ten largest holdings make up 19% of its $1.42B portfolio in Q2 2013.
- Profund Advisors disclosed 1,386 positions in Q2 2013, its first 13F filing on record.
Based on Profund Advisors's 13F filing for Q2 2013, filed 25 Jul 2013.